Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)
Heidelberg, Baden-Württemberg, Germany
Research institute in Heidelberg, Baden-Württemberg
Im Neuenheimer Feld 460, 69120 Heidelberg
About Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Nationwide Children's Hospital
3
Clinical Trials at Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)
During the past decade, Hopp Children's Cancer Center at NCT Heidelberg (KiTZ) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
2021-04-08
2025-12-01
Recruiting
15
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
2022-12-16
2026-12-01
Recruiting
38
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
2023-04-10
2027-04-10
Recruiting
38
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)"
#1 collaborator was "Children's Hospital Colorado" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)
According to Clinical.Site data, the most researched conditions in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)" are
"Recurrent Adamantinomatous Craniopharyngioma" (2 trials), "Adamantinomatous Craniopharyngioma" (1 trials), "Adamantinous Craniopharyngioma" (1 trials), "Diffuse Intrinsic Pontine Glioma" (1 trials) and "High Grade Glioma" (1 trials). Many other conditions were trialed in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)" in a lesser frequency.
Clinical Trials Intervention Types at Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)
Most popular intervention types in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Binimetinib Oral Tablet [Mektovi]" (1 trials), "Larotrectinib" (1 trials), "Larotrectinib surgical" (1 trials) and "Tocilizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)
The vast majority of trials in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)" are
3 trials for "All" genders.
Clinical Trials Status at Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)
Currently, there are NaN active trials in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Hopp Children's Cancer Center at NCT Heidelberg (KiTZ),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hopp Children's Cancer Center at NCT Heidelberg (KiTZ), 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".